AEK-7612625-6/11/1

AbbVie Deutschland GmbH & Co. KG — FEI 3002807401

Refusal Details

Date
September 8, 2020
Country
Germany
Product Category
Drugs and Biologics
Product Code
61YDY02 ADALIMUMAB
Charges
75